Clinical Trial: Hypertension Registry of "Hypertension Prevention and Control Initiative in China"

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT04289701) titled 'Hypertension Registry of "Hypertension Prevention and Control Initiative in China"' on Feb. 25.

Brief Summary: Hypertension is the leading preventable risk factor of cardiovascular disease globally and in China. Unparalleled to remarkable increase of hypertension burden in China, blood pressure(BP) control is inadequate. A political public health project, "Hypertension Prevention and Control Initiative in China(Chronic Disease Demonstration District Construction)", was initiated in October 2019 for explore a feasible and reproducible archetype for hypertension management and to improve the registration, management, treatment and co...